残疾改善与多发性硬化患者脑萎缩进展较少相关
该研究随访980例多发性硬化患者平均4.8±2.4年,按扩展残疾状态量表变化分为残疾进展组(n=241)、残疾改善组(n=101)和稳定组(n=638)。结果显示残疾改善组年化侧脑室体积变化百分比最低(1.6%±2.7%),稳定组为2.1%±3.7%,残疾进展组为4.1%±5.5%(P<.001);年化全脑体积变化百分比在残疾改善组为-0.7%±0.7%,稳定组为-0.8%±0.7%,残疾进展组为-1.1%±1.1%(P=.001)。结论认为临床残疾改善的多发性硬化患者随时间推移脑萎缩进展较少。
要点
- 随访期间残疾改善组年化侧脑室体积变化百分比最低(1.6%±2.7%),稳定组为2.1%±3.7%,进展组为4.1%±5.5%(P<.001)。
- 年化全脑体积变化百分比在残疾改善组为-0.7%±0.7%,稳定组为-0.8%±0.7%,残疾进展组为-1.1%±1.1%(P=.001)。
- 基线时三组全脑体积(P=.71)和侧脑室体积(P=.74)均无差异。
核心结论
- 多发性硬化患者中,临床残疾改善者随时间推移脑萎缩进展少于残疾进展者。
研究设计与样本
- 随访980例多发性硬化患者平均4.8±2.4年,分为残疾进展组(n=241,24.6%)、残疾改善组(n=101,10.3%)和稳定组(n=638,65.1%);残疾改善和残疾进展依据标准化指南的扩展残疾状态量表评分变化定义,稳定定义为未发生残疾进展或残疾改善;采用SIENAX在3D T1WI上计算标准化全脑体积,采用NeuroSTREAM在2D-T2-FLAIR图像上测量侧脑室,分别用SIENA和NeuroSTREAM计算脑体积变化百分比和侧脑室体积变化百分比;组间差异采用ANCOVA分析,校正首次MR成像时年龄、种族、T2病灶体积、相应基线结构体积和扩展残疾状态量表评分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: It is unknown whether deceleration of brain atrophy is associated with disability improvement in patients with MS. Our aim was to investigate whether patients with MS with disability improvement develop less brain atrophy compared with those who progress in disability or remain stable.
MATERIALS AND METHODS: We followed 980 patients with MS for a mean of 4.8 ± 2.4 years. Subjects were divided into 3 groups: progress in disability (n = 241, 24.6%), disability improvement (n = 101, 10.3%), and stable (n = 638, 65.1%) at follow-up. Disability improvement and progress in disability were defined on the basis of the Expanded Disability Status Scale score change using standardized guidelines. Stable was defined as nonoccurrence of progress in disability or disability improvement. Normalized whole-brain volume was calculated using SIENAX on 3D T1WI, whereas the lateral ventricle was measured using NeuroSTREAM on 2D-T2-FLAIR images. The percentage brain volume change and percentage lateral ventricle volume change were calculated using SIENA and NeuroSTREAM, respectively. Differences among groups were investigated using ANCOVA, adjusted for age at first MR imaging, race, T2 lesion volume, and corresponding baseline structural volume and the Expanded Disability Status Scale.
RESULTS: At first MR imaging, there were no differences among progress in disability, disability improvement, and the stable groups in whole-brain volume (P = .71) or lateral ventricle volume (P = .74). During follow-up, patients with disability improvement had the lowest annualized percentage lateral ventricle volume change (1.6% ± 2.7%) followed by patients who were stable (2.1% ± 3.7%) and had progress in disability (4.1% ± 5.5%), respectively (P < .001). The annualized percentage brain volume change values were -0.7% ± 0.7% for disability improvement, -0.8% ± 0.7% for stable, and -1.1% ± 1.1% for progress in disability (P = .001).
CONCLUSIONS: Patients with MS who improve in their clinical disability develop less brain atrophy across time compared with those who progress.
引用
- Ghione E, Bergsland N, Dwyer MG, et al. Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple Sclerosis. AJNR Am J Neuroradiol. 2020. PMID: 32763899. doi:10.3174/ajnr.A6684
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。